Maternal Type 1collagen N-terminal Telopeptide Levels in Severe Hyperemesis Gravidarum

Overview

Journal BMC Pregnancy Childbirth

Publisher Biomed Central

Specialty Gynecology & Obstetrics

Date 2018 Dec 22

PMID 30572827

Authors

E Sahin

Y Madendag

M Eraslan Sahin

A T Tayyar

I Col Madendag

M Gozukucuk

C Karakukcu

G Acmaz

I I Muderris

Affiliations

Soon will be listed here.

Abstract

Background: Nausea and vomiting occur 50-90% during the first trimester of pregnancy. However, patients with hyperemesis gravidarum (HG) may be hospitalized at an incidence rate of 0.8-2% before the 20th week of gestational age. The symptoms generally start during the 5-6th gestational weeks, reaching the highest degree during the 9th week, and decline after the 16-20th weeks of gestation. Clinical findings are proportional to the severity of the disease and severe HG is characterized with dehydration, electrolyte imbalance, and nutritional deficiency as a result of vomiting.

Methods: The study population consisted of two groups of pregnant volunteers at 5-12 weeks of gestation: a severe HG group and a control group. The HG severity was scored using the Pregnancy-Unique Quantification of Emesis (and nausea) (PUQE).The serum levels of the maternal Ca, parathyroid hormone (PTH), Na, K, blood urea nitrogen(BUN), creatinine, vitamin D(25OHD3), and the maternal urine NTx levels were compared between the groups.

Results: In total, 40 volunteers were enrolled in this study: 20 healthy pregnant volunteers and 20 with severe HG. There were no statistically significant differences between the maternal characteristics. The first trimester weight loss of ≥5 kg was significantly higher in the severe HG group (p < 0.001), while the control group had a significantly higher sunlight exposure ratio than the severe HG group (p = 0.021). The urine NTx levels were significantly higher in the severe HG group (39.22 ± 11.68NTx/Cre) than in the control group(32.89 ± 8.33NTx/Cre) (p = 0.028).The serum Ca, PTH, Na, K, BUN, and creatinine levels were similar between the groups (p = 0.738, p = 0.886, p = 0.841, p = 0.957, p = 0.892, and p = 0.824, respectively). In the severe HG group, the serum 25OHD levels were significantly lower than in the control group (p < 0.001).

Conclusions: The data from this study indicated that severe HG is associated with increased urine NTx levels. However, large-scale studies are required to understand the clinical significance of this finding, as well as the long-term consequences of elevated urine NTx levels and the underlying mechanisms.

Trial Registration: NCT02862496 Date of registration: 21/07/2016.

References

Sowers M, Scholl T, Harris L, Jannausch M . Bone loss in adolescent and adult pregnant women. Obstet Gynecol. 2000; 96(2):189-93. DOI: 10.1016/s0029-7844(00)00903-0. View

Prentice A . Calcium in pregnancy and lactation. Annu Rev Nutr. 2000; 20:249-72. DOI: 10.1146/annurev.nutr.20.1.249. View

Janakiraman V, Ettinger A, Mercado-Garcia A, Hu H, Hernandez-Avila M . Calcium supplements and bone resorption in pregnancy: a randomized crossover trial. Am J Prev Med. 2003; 24(3):260-4. DOI: 10.1016/s0749-3797(02)00641-4. View

HANSON D, Weis M, Bollen A, Maslan S, Singer F, Eyre D . A specific immunoassay for monitoring human bone resorption: quantitation of type I collagen cross-linked N-telopeptides in urine. J Bone Miner Res. 1992; 7(11):1251-8. DOI: 10.1002/jbmr.5650071119. View

Chiossi G, Neri I, Cavazzuti M, Basso G, Facchinetti F . Hyperemesis gravidarum complicated by Wernicke encephalopathy: background, case report, and review of the literature. Obstet Gynecol Surv. 2006; 61(4):255-68. DOI: 10.1097/01.ogx.0000206336.08794.65. View

Ismail S, Kenny L . Review on hyperemesis gravidarum. Best Pract Res Clin Gastroenterol. 2007; 21(5):755-69. DOI: 10.1016/j.bpg.2007.05.008. View

Bonjour J, Chevalley T, Ferrari S, Rizzoli R . The importance and relevance of peak bone mass in the prevalence of osteoporosis. Salud Publica Mex. 2009; 51 Suppl 1:S5-17. DOI: 10.1590/s0036-36342009000700004. View

Cooper C, Harvey N, Cole Z, Hanson M, Dennison E . Developmental origins of osteoporosis: the role of maternal nutrition. Adv Exp Med Biol. 2009; 646:31-9. DOI: 10.1007/978-1-4020-9173-5_3. View

Lenora J, Lekamwasam S, Karlsson M . Effects of multiparity and prolonged breast-feeding on maternal bone mineral density: a community-based cross-sectional study. BMC Womens Health. 2009; 9:19. PMC: 2720947. DOI: 10.1186/1472-6874-9-19. View

10.

Liu Z, Qiu L, Chen Y, Su Y . Effect of milk and calcium supplementation on bone density and bone turnover in pregnant Chinese women: a randomized controlled trail. Arch Gynecol Obstet. 2010; 283(2):205-11. DOI: 10.1007/s00404-009-1345-0. View

11.

Holick M, Binkley N, Bischoff-Ferrari H, Gordon C, Hanley D, Heaney R . Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011; 96(7):1911-30. DOI: 10.1210/jc.2011-0385. View

12.

Mullin P, Ching C, Schoenberg F, MacGibbon K, Romero R, Goodwin T . Risk factors, treatments, and outcomes associated with prolonged hyperemesis gravidarum. J Matern Fetal Neonatal Med. 2011; 25(6):632-6. PMC: 3560915. DOI: 10.3109/14767058.2011.598588. View

13.

Lawlor D, Wills A, Fraser A, Sayers A, Fraser W, Tobias J . Association of maternal vitamin D status during pregnancy with bone-mineral content in offspring: a prospective cohort study. Lancet. 2013; 381(9884):2176-83. PMC: 3691477. DOI: 10.1016/S0140-6736(12)62203-X. View

14.

Zhu K, Whitehouse A, Hart P, Kusel M, Mountain J, Lye S . Maternal vitamin D status during pregnancy and bone mass in offspring at 20 years of age: a prospective cohort study. J Bone Miner Res. 2013; 29(5):1088-95. DOI: 10.1002/jbmr.2138. View

15.

Hlaing T, Compston J . Biochemical markers of bone turnover - uses and limitations. Ann Clin Biochem. 2014; 51(Pt 2):189-202. DOI: 10.1177/0004563213515190. View

16.

Corona G, Simonetti L, Giuliani C, Sforza A, Peri A . A case of osmotic demyelination syndrome occurred after the correction of severe hyponatraemia in hyperemesis gravidarum. BMC Endocr Disord. 2014; 14:34. PMC: 3989779. DOI: 10.1186/1472-6823-14-34. View

17.

Karras S, Anagnostis P, Annweiler C, Naughton D, Petroczi A, Bili E . Maternal vitamin D status during pregnancy: the Mediterranean reality. Eur J Clin Nutr. 2014; 68(8):864-9. DOI: 10.1038/ejcn.2014.80. View

18.

Sanz-Salvador L, Garcia-Perez M, Tarin J, Cano A . Bone metabolic changes during pregnancy: a period of vulnerability to osteoporosis and fracture. Eur J Endocrinol. 2014; 172(2):R53-65. DOI: 10.1530/EJE-14-0424. View

19.

Ettinger A, Lamadrid-Figueroa H, Mercado-Garcia A, Kordas K, Wood R, Peterson K . Effect of calcium supplementation on bone resorption in pregnancy and the early postpartum: a randomized controlled trial in Mexican women. Nutr J. 2014; 13(1):116. PMC: 4289552. DOI: 10.1186/1475-2891-13-116. View

20.

Shigemi D, Nakanishi K, Miyazaki M, Shibata Y, Suzuki S . A case of maternal vitamin K deficiency associated with hyperemesis gravidarum: its potential impact on fetal blood coagulability. J Nippon Med Sch. 2015; 82(1):54-8. DOI: 10.1272/jnms.82.54. View